# Physiological metabolic analysis and process optimization of hypoxia in promoting coenzyme Q10 biosynthesis and accumulation in Rhodobacter sphaeroides HY01

**Authors:** Bo Li, Yan Ge, Li Fu, Huanan Guo, Ali Mohsin, Junming Li, Jiequn Wu, Biqin Chen, Yingping Zhuang, Zejian Wang

PMC · DOI: 10.1016/j.synbio.2026.02.001 · 2026-02-14

## TL;DR

This study explores how hypoxia promotes Coenzyme Q10 production in Rhodobacter sphaeroides by analyzing metabolic changes and cell morphology.

## Contribution

The study reveals that Coenzyme Q10 accumulation is linked to cell volume expansion rather than biosynthetic pathway upregulation.

## Key findings

- Metabolic pathways for Coenzyme Q10 biosynthesis are downregulated under hypoxia.
- Cell morphology and Coenzyme Q10 yield are strongly correlated, with larger cells producing more Coenzyme Q10.
- Adding unsaturated fatty acids increased Coenzyme Q10 yield by 18.9%.

## Abstract

Coenzyme Q10 fermentation by Rhodobacter sphaeroides (R. sphaeroides) is highly aerobic. However, its biosynthesis and accumulation are paradoxically induced under hypoxic conditions. While oxygen serves as both an induction signal and a key precursor, the mechanisms underlying Coenzyme Q10 accumulation under hypoxia remain elusive, posing a significant bottleneck for yield improvement. This study systematically elucidated these mechanisms through transcriptomic analysis. Results revealed that metabolic pathways for precursor and Coenzyme Q10 biosynthesis were, surprisingly, downregulated under hypoxia. Conversely, genes inhibiting morphological remodeling were downregulated, while those involved in cell membrane biosynthesis were upregulated. Furthermore, a significant positive correlation was observed between cellular morphology and Coenzyme Q10 yield. Specifically, under varying hypoxic conditions, cell morphology and Coenzyme Q10 yield also exhibited strong correlations, with higher yields were associated with larger cell volumes. These findings suggest that R. sphaeroides enhances Coenzyme Q10 accumulation primarily by expanding the cell volume and membrane surface area rather than upregulating biosynthetic pathways. Leveraging this insight, the addition of unsaturated fatty acids further increasing the Coenzyme Q10 yield by 18.9%. This study provides a novel strategy for enhancing Coenzyme Q10 production through morphological engineering and process optimization.

## Linked entities

- **Chemicals:** Coenzyme Q10 (PubChem CID 5281915)

## Full-text entities

- **Diseases:** Hypoxia (MESH:D000860), Hypoxic (MESH:D002534), OUR (MESH:C536778), ND (MESH:C537849), CCM (MESH:D001928)
- **Chemicals:** PHB (MESH:C038193), biotin (MESH:D001710), Xylulose-5-phosphate (MESH:C031625), lupeol (MESH:C010480), Ribulose-5-phosphate (MESH:C031524), S-adenosyl-l-homocysteine (MESH:D012435), Sedoheptulose-7-phosphate (MESH:C020495), poly-gamma-glutamic acid (MESH:C511775), water (MESH:D014867), Phospholipids (MESH:D010743), nicotinamide (MESH:D009536), phosphoenolpyruvate (MESH:D010728), acetyl-CoA (MESH:D000105), 3-Phosphoglycerate (MESH:C005156), disaccharide (MESH:D004187), Isoprenoid (MESH:D013729), palm oil (MESH:D000073878), S-adenosyl-l-methionine (MESH:D012436), nitrogen (MESH:D009584), K2HPO4 (MESH:C013216), NH4Cl (MESH:D000643), choline chloride (MESH:D002794), Glucose-6-phosphate (MESH:D019298), agar (MESH:D000362), pentose phosphate (MESH:D010428), CoQ10 (MESH:C024989), glyceraldehyde-3-phosphate (MESH:D005986), carbon (MESH:D002244), tricarboxylic acid (MESH:D014233), ferrous sulfate (MESH:C020748), methionine (MESH:D008715), pyruvate (MESH:D019289), CaCO3 (MESH:D002119), NaCl (MESH:D012965), peanut oil (MESH:D000074241), sugar (MESH:D000073893), ammonia (MESH:D000641), pyridoxine (MESH:D011736), Oxygen (MESH:D010100), NADH (MESH:D009243), MEP (MESH:C064603), Quinone (MESH:C004532), IPP (MESH:C004809), CoCl2 (MESH:C018021), glucose (MESH:D005947), folic acid (MESH:D005492), calcium pantothenate (MESH:D010205), ATP (MESH:D000255), beta-carotene (MESH:D019207), cysteine (MESH:D003545), lipid (MESH:D008055), lipopolysaccharide (MESH:D008070), ammonium sulfate (MESH:D000645), ubiquinone (MESH:D014451), niacin (MESH:D009525), corn oil (MESH:D003314), OAA (MESH:D062907), shikimate (MESH:C000723335), MgSO4 (MESH:D008278), thiamine (MESH:D013831)
- **Species:** Legionella sp. I (species) [taxon 66967], Bacillus amyloliquefaciens (species) [taxon 1390], Yarrowia lipolytica (species) [taxon 4952], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Candida tropicalis (species) [taxon 5482], Cereibacter sphaeroides (species) [taxon 1063], Ensifer adhaerens (species) [taxon 106592], Escherichia coli (E. coli, species) [taxon 562], Agrobacterium tumefaciens (species) [taxon 358], Rhodotorula glutinis (species) [taxon 5535]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924739/full.md

---
Source: https://tomesphere.com/paper/PMC12924739